ATE442146T1 - Pharmazeutische zusammensetzung mit prostaglandin - Google Patents
Pharmazeutische zusammensetzung mit prostaglandinInfo
- Publication number
- ATE442146T1 ATE442146T1 AT04818172T AT04818172T ATE442146T1 AT E442146 T1 ATE442146 T1 AT E442146T1 AT 04818172 T AT04818172 T AT 04818172T AT 04818172 T AT04818172 T AT 04818172T AT E442146 T1 ATE442146 T1 AT E442146T1
- Authority
- AT
- Austria
- Prior art keywords
- prostaglandin
- pharmaceutical composition
- composition containing
- water
- containing prostaglandin
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 150000003180 prostaglandins Chemical class 0.000 title 1
- PXGPLTODNUVGFL-BRIYLRKRSA-N (E,Z)-(1R,2R,3R,5S)-7-(3,5-Dihydroxy-2-((3S)-(3-hydroxy-1-octenyl))cyclopentyl)-5-heptenoic acid Chemical compound CCCCC[C@H](O)C=C[C@H]1[C@H](O)C[C@H](O)[C@@H]1CC=CCCCC(O)=O PXGPLTODNUVGFL-BRIYLRKRSA-N 0.000 abstract 3
- 230000015556 catabolic process Effects 0.000 abstract 1
- 238000006731 degradation reaction Methods 0.000 abstract 1
- 150000004667 medium chain fatty acids Chemical class 0.000 abstract 1
- 239000007764 o/w emulsion Substances 0.000 abstract 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
- 229920003169 water-soluble polymer Polymers 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/113—Multiple emulsions, e.g. oil-in-water-in-oil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dispersion Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2003378196 | 2003-11-07 | ||
| PCT/JP2004/015828 WO2005044276A1 (ja) | 2003-11-07 | 2004-10-26 | プロスタグランジン含有医薬組成物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE442146T1 true ATE442146T1 (de) | 2009-09-15 |
Family
ID=34567167
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04818172T ATE442146T1 (de) | 2003-11-07 | 2004-10-26 | Pharmazeutische zusammensetzung mit prostaglandin |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20080139652A1 (de) |
| EP (1) | EP1681059B1 (de) |
| JP (1) | JP4762718B2 (de) |
| KR (1) | KR101091461B1 (de) |
| CN (1) | CN100484528C (de) |
| AT (1) | ATE442146T1 (de) |
| DE (1) | DE602004023106D1 (de) |
| ES (1) | ES2331313T3 (de) |
| PL (1) | PL1681059T3 (de) |
| WO (1) | WO2005044276A1 (de) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2578176C (en) | 2004-11-09 | 2013-09-24 | Novagali Pharma Sa | Ophthalmic emulsions containing an immunosuppressive agent |
| ATE485479T1 (de) | 2005-03-31 | 2010-11-15 | Neobulb Technologies Inc | Hochleistungs-led-beleuchtungseinrichtung mit hohem thermischen diffusionsvermögen |
| US8030349B2 (en) * | 2005-08-02 | 2011-10-04 | Santen Pharmaceutical Co., Ltd. | Method for prevention of degradation of thermally unstable medicament |
| JP5122460B2 (ja) * | 2005-09-16 | 2013-01-16 | アラーガン、インコーポレイテッド | 治療薬の眼内輸送のための組成物および方法 |
| CN101282714B (zh) * | 2005-10-10 | 2012-12-12 | 诺瓦加利制药公司 | 包含前列腺素的眼用乳剂 |
| WO2007105691A1 (ja) * | 2006-03-13 | 2007-09-20 | R-Tech Ueno, Ltd. | 水性組成物 |
| DE102006049091A1 (de) * | 2006-10-18 | 2008-04-24 | Dr. Gerhard Mann Chem.-Pharm. Fabrik Gmbh | Emulgatorfreies ophthalmisches Präparat enthaltend Pflanzenöl |
| EP2123278B1 (de) | 2007-02-07 | 2013-01-09 | Teika Pharmaceutical Co., Ltd. | Augentropfenzubereitung mit latanoprost |
| EP1985298A1 (de) * | 2007-04-24 | 2008-10-29 | Azad Pharma AG | Prostaglandinhaltige Öl-in-Wasser-Emulsionen für das Auge |
| FR2916636B1 (fr) * | 2007-05-29 | 2009-09-04 | Octalia Technologies | Vehicule sous forme d'une emulsion huile-dans-eau notamment destine a une utilisation ophtalmique ou dermocosmetique |
| EP2172202A4 (de) | 2007-06-29 | 2010-06-30 | Taisho Pharmaceutical Co Ltd | Ein prostagland-derivat enthaltendes wässriges flüssiges mittel |
| JP2009073788A (ja) * | 2007-09-21 | 2009-04-09 | Teika Seiyaku Kk | イソプロピルウノプロストン含有眼用組成物 |
| TW201010708A (en) * | 2008-06-02 | 2010-03-16 | Intervet Int Bv | Composition comprising an antibiotic and a corticosteroid |
| FR2938757B1 (fr) * | 2008-11-27 | 2010-12-31 | Octalia Technologies | Vehicule sous forme d'une emulsion huile-dans-eau notamment destine a une utilisation cosmetique ou dermatologique |
| EP2228058A1 (de) * | 2009-03-04 | 2010-09-15 | Novagali Pharma S.A. | Anionische Öl-in-Wasser-Emulsion mit Prostaglandinen und Verwendungen dafür |
| NZ716349A (en) | 2009-11-09 | 2017-07-28 | Allergan Inc | Compositions and methods for stimulating hair growth |
| US20110112198A1 (en) * | 2009-11-09 | 2011-05-12 | Allergan, Inc. | Compositions for enhancing hair growth |
| EP2389939A1 (de) | 2010-05-28 | 2011-11-30 | Novagali Pharma S.A. | Verwendung von Prostaglandinen F2alpha und Analoga zur Heilung von Horn- und Bindehautläsionen |
| IT1404931B1 (it) * | 2010-06-11 | 2013-12-09 | Medivis S R L | Composizioni oftalmiche per la somministrazione di principi attivi liposolubili . |
| CA2837240A1 (en) * | 2011-05-27 | 2012-12-06 | Ratiopharm Gmbh | Ophthalmic preparation comprising a pgf2.alpha. analogue |
| US9278132B2 (en) * | 2012-02-13 | 2016-03-08 | Bausch & Lomb Incorporated | Ophthalmic pharmaceutical compositions and methods of making and using same |
| EP2956096A1 (de) | 2013-02-15 | 2015-12-23 | Allergan, Inc. | Implantat mit langzeit-wirkstofffreisetzung |
| EP3520778B1 (de) | 2016-11-17 | 2024-04-10 | Senju Pharmaceutical Co., Ltd. | Emulsionsaugentropfen |
| KR20200035047A (ko) * | 2017-08-03 | 2020-04-01 | 산텐 세이야꾸 가부시키가이샤 | 클로르헥시딘을 함유하는 의약 조성물 |
| KR102365008B1 (ko) * | 2020-06-23 | 2022-02-23 | 주식회사태준제약 | 디쿠아포솔을 포함하는 점안 조성물 |
| CN115400074A (zh) * | 2021-05-27 | 2022-11-29 | 山东新时代药业有限公司 | 拉坦前列素滴眼液及其制备方法 |
| CN115463088A (zh) * | 2021-06-11 | 2022-12-13 | 温士顿医药股份有限公司 | 含前列腺素衍生物的眼用纳米乳剂组合物 |
| WO2024015959A1 (en) | 2022-07-15 | 2024-01-18 | Praful Doshi | Methods of making and using contact lenses including medicaments and stabilizers of labile components such as drugs |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2714065A1 (de) * | 1977-03-30 | 1978-10-12 | Boehringer Mannheim Gmbh | Instillationszubereitung |
| JPS6051105A (ja) * | 1983-08-30 | 1985-03-22 | Green Cross Corp:The | プロスタグランジン脂肪乳剤 |
| CA1324129C (en) | 1987-04-30 | 1993-11-09 | Ryuzo Ueno | Prostaglandins of the f series |
| US4839371A (en) * | 1987-09-17 | 1989-06-13 | Smithkline Beckman Corporation | 3-aralkyl-2-mercaptoyridines as dopamine-β-hydroxylase inhibitors |
| GB2209939B (en) * | 1987-09-18 | 1992-01-02 | R Tech Ueno Ltd | The use of 13,14-dihydro-15-keto-prostaglandins as ocular hypotensive agents |
| US5192535A (en) | 1988-02-08 | 1993-03-09 | Insite Vision Incorporated | Ophthalmic suspensions |
| JP2597629B2 (ja) * | 1988-02-26 | 1997-04-09 | 株式会社 上野製薬応用研究所 | １３，１４−ジヒドロ−１５−ケトプロスタグランジン類の安定化 |
| DE68929435T2 (de) * | 1988-09-06 | 2003-07-17 | Pharmacia Ab, Stockholm | Prostaglandinderivate zur Behandlung des grünen Stars oder einer okularen Hypertension |
| US5296504A (en) * | 1988-09-06 | 1994-03-22 | Kabi Pharmacia | Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension |
| JPH0710833A (ja) | 1991-04-16 | 1995-01-13 | Yutaka Mizushima | プロスタグランジン類縁体、その脂肪乳剤およびその用途 |
| US5352708A (en) * | 1992-09-21 | 1994-10-04 | Allergan, Inc. | Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents |
| US5510383A (en) * | 1993-08-03 | 1996-04-23 | Alcon Laboratories, Inc. | Use of cloprostenol, fluprostenol and their salts and esters to treat glaucoma and ocular hypertension |
| US5631287A (en) * | 1994-12-22 | 1997-05-20 | Alcon Laboratories, Inc. | Storage-stable prostaglandin compositions |
| US5767153A (en) | 1995-06-07 | 1998-06-16 | Insite Vision Incorporated | Sustained release emulsions |
| US5767135A (en) * | 1995-12-29 | 1998-06-16 | Fernandez-Pol; Jose Alberto | Antiviral agent |
| US6066671A (en) * | 1997-12-19 | 2000-05-23 | Alcon Laboratories, Inc. | Treatment of GLC1A glaucoma with 3-benzoyl-phenylacetic acids, esters, or amides |
| JP4421699B2 (ja) | 1999-06-30 | 2010-02-24 | 大洋薬品工業株式会社 | 静脈注射可能なプロスタグランジン脂肪乳剤 |
| US20020013294A1 (en) * | 2000-03-31 | 2002-01-31 | Delong Mitchell Anthony | Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives |
| PT1321144E (pt) * | 2000-09-13 | 2011-03-10 | Santen Pharmaceutical Co Ltd | Colírio |
| JP3876355B2 (ja) | 2000-09-13 | 2007-01-31 | 参天製薬株式会社 | 点眼液 |
| US6635654B1 (en) * | 2003-01-09 | 2003-10-21 | Allergan, Inc. | Ophthalmic compositions containing loratadine |
-
2004
- 2004-10-26 DE DE602004023106T patent/DE602004023106D1/de not_active Expired - Lifetime
- 2004-10-26 AT AT04818172T patent/ATE442146T1/de not_active IP Right Cessation
- 2004-10-26 WO PCT/JP2004/015828 patent/WO2005044276A1/ja not_active Ceased
- 2004-10-26 KR KR1020067010544A patent/KR101091461B1/ko not_active Expired - Fee Related
- 2004-10-26 US US10/573,191 patent/US20080139652A1/en not_active Abandoned
- 2004-10-26 JP JP2005515261A patent/JP4762718B2/ja not_active Expired - Fee Related
- 2004-10-26 PL PL04818172T patent/PL1681059T3/pl unknown
- 2004-10-26 ES ES04818172T patent/ES2331313T3/es not_active Expired - Lifetime
- 2004-10-26 EP EP04818172A patent/EP1681059B1/de not_active Expired - Lifetime
- 2004-10-26 CN CNB2004800315504A patent/CN100484528C/zh not_active Expired - Fee Related
-
2011
- 2011-08-10 US US13/206,784 patent/US8697751B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP1681059A4 (de) | 2007-10-10 |
| US20110294880A1 (en) | 2011-12-01 |
| JP4762718B2 (ja) | 2011-08-31 |
| KR101091461B1 (ko) | 2011-12-07 |
| EP1681059A1 (de) | 2006-07-19 |
| CN1871014A (zh) | 2006-11-29 |
| KR20060123215A (ko) | 2006-12-01 |
| WO2005044276A1 (ja) | 2005-05-19 |
| JPWO2005044276A1 (ja) | 2007-05-17 |
| US20080139652A1 (en) | 2008-06-12 |
| DE602004023106D1 (de) | 2009-10-22 |
| PL1681059T3 (pl) | 2010-01-29 |
| ES2331313T3 (es) | 2009-12-29 |
| EP1681059B1 (de) | 2009-09-09 |
| CN100484528C (zh) | 2009-05-06 |
| US8697751B2 (en) | 2014-04-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE602004023106D1 (de) | Pharmazeutische zusammensetzung mit prostaglandin | |
| EA200801602A1 (ru) | Эмульсия | |
| KR890011586A (ko) | 지용성물질의 수용액 | |
| CR7999A (es) | Metodos y composiciones farmaceuticas para la obtencion confiable de niveles aceptables de testosterona en suero | |
| AR032200A1 (es) | Productos antitranspirantes | |
| DE60216944D1 (de) | Mikrobizide formulierung die essentielle öle oder deren derivate enthält | |
| AR113749A1 (es) | Formulaciones cannabinoides sintéticas y a base de plantas de inicio rápido y acción prolongada | |
| UY31633A1 (es) | Plaguicidas mesoiónicos | |
| DOP2012000261A (es) | Formulaciones de insulina de accion prolongada | |
| ATE469641T1 (de) | Pharmazeutische formulierung mit statinmikrokapseln in alkylestern mehrfach ungesättigter fettsäuren | |
| AR067944A1 (es) | Compuesto que comprende un aceite que contiene acidos grasos poliinsaturados de cadena larga y lecitina | |
| AR011846A1 (es) | Una composicion farmaceutica, y el procedimiento para prepararla | |
| BRPI0413845A (pt) | antioxidante que é baseado em ácido ascórbico, uso do antioxidante, e, preparação de gordura alimentìcia ou óleo alimentìcio | |
| BRPI0418330A (pt) | composições sólidas de drogas de solubilidade baixa e poloxámeros | |
| EA200600528A1 (ru) | Способ получения водорастворимых дитерпенов и их применение | |
| DE602006017057D1 (de) | Dehydracetsäure enthaltende hautpflegezusammensetzungen mit niedrigem ph | |
| CH700328B8 (de) | O/W-Emulsion zur Pflege der Hand. | |
| BRPI0413491A (pt) | sistema de gordura vegetal hidrogenada | |
| AR120027A1 (es) | Emulsión de aceite en agua que comprende proteína vegetal | |
| MA29481B1 (fr) | Derives d'azolopyridine-2-one en tant qu'inhibiteurs de lipase et de phospholipase | |
| ES2531599T3 (es) | Utilización de triglicéridos docosahexaenoicos para el tratamiento de enfermedades tumorales | |
| AR046189A1 (es) | Una composicion biocida no fitotoxico que contiene aceite de arbusto de te y metodo de produccion de la misma | |
| MX2012010935A (es) | Formulacion acuosa estable mejorada de (e)-4-carboxiestiril-4-clor obencil sulfona. | |
| EP1623697A4 (de) | Kosmetische öl-in-wasser-emulsion | |
| CY1112023T1 (el) | Φαρμακοτεχνικη μορφη νιτροοξυπαραγωγων των nsaids |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |